Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Laguna Hills, California 92656


Purpose:

The objective is to determine the effect of Isoprinosine (inosine pranobex) in homosexual male patients with AIDS related complex (ARC) in delaying the onset of AIDS. Secondly, to determine the effect of Isoprinosine in decreasing the severity and/or incidence of lesser opportunistic infections and/or other conditions associated with ARC.


Criteria:

Exclusion Criteria Concurrent Medication: Excluded: - Cardiac glycosides. Patients with the following are excluded: - AIDS. - Presenting with chronic candida infection-colo/rectal, oral/pharyngeal, cutaneous (finger/toenails) - for = or > 3 months who have not responded to therapy. - Critical illness. - Hemophilia. Prior Medication: Excluded within 1 month of study entry: - Steroids. - Cytotoxic immunosuppressive agents. - Radiotherapy and/or systemic antiviral medication. - Immunomodulators (including Isoprinosine). Prior Treatment: Excluded within 1 month of study entry: - Radiotherapy. History of gout, uric acid urolithiasis, uric acid nephrolithiasis, or renal dysfunction. - Lymphoid malignancy. Homosexual male patients with AIDS related complex (ARC). Current IV drug abuse.


NCT ID:

NCT00002060


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Laguna Hills, California 92656
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: September 21, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.